Endonasal endoscopic transsphenoidal pituitary surgery: Early experience and outcome in paediatric Cushing's disease

Background Selective adenomectomy remains the first-line treatment for Cushing's disease (CD), until recently by microscopic transsphenoidal pituitary surgery. Endonasal transsphenoidal endoscopic surgery (ETES) is emerging as a novel, less invasive treatment for pituitary adenomas and has beco...

Full description

Bibliographic Details
Main Authors: Storr, H, Drake, WM, Evanson, J, Matson, M, Berney, D, Grossman, A, Akker, SA, Monson, J, Alusi, G, Savage, M, Sabin, I
Format: Journal article
Published: 2014
_version_ 1797084738598469632
author Storr, H
Drake, WM
Evanson, J
Matson, M
Berney, D
Grossman, A
Akker, SA
Monson, J
Alusi, G
Savage, M
Savage, M
Sabin, I
author_facet Storr, H
Drake, WM
Evanson, J
Matson, M
Berney, D
Grossman, A
Akker, SA
Monson, J
Alusi, G
Savage, M
Savage, M
Sabin, I
author_sort Storr, H
collection OXFORD
description Background Selective adenomectomy remains the first-line treatment for Cushing's disease (CD), until recently by microscopic transsphenoidal pituitary surgery. Endonasal transsphenoidal endoscopic surgery (ETES) is emerging as a novel, less invasive treatment for pituitary adenomas and has become the optimal surgical approach. Objective There are no published series for the treatment of paediatric CD by ETES, and we report our centre's preliminary results. Design Retrospective analysis. Patients Six paediatric patients (median age 15·8 years; range 11·7-17·0 years) fulfilled standard diagnostic criteria for CD. Preoperatively, no abnormality was identified on pituitary MR scanning in 3 (50%) patients, one had a macroadenoma. Bilateral petrosal sinus sampling demonstrated central ACTH secretion (IPS/P ACTH ratio ≥3·0, post-CRH) in 3/6 (50%) patients. The same neurosurgeon and endoscopic nasal surgeon undertook all the operations. Outcome measures Therapeutic outcome and rate of complications. Results Clinical recovery and biochemical 'cure' were achieved in 5 (83%) patients, and a corticotroph adenoma was confirmed histologically in all cured cases. One case developed post-operative CSF leak requiring lumbar drain insertion and patching. At a mean interval of 4·7 years (0·1-10·8 years) post-operatively, cured patients have shown no recurrence. One patient, with a large diffuse adenoma requiring more extensive surgery, has panhypopituitarism, and another patient has GH and gonadotrophin deficiencies. Conclusions Our experience shows that ETES for removing corticotroph adenomas in children, in most cases not visualized on MRI, is minimally invasive and gave excellent post-operative recovery/results. In skilled hands, this technique provides an alternative to conventional transsphenoidal microscopic surgery in managing paediatric CD. © 2013 John Wiley and Sons Ltd.
first_indexed 2024-03-07T01:59:13Z
format Journal article
id oxford-uuid:9cc39cdb-d7d1-473f-9ad4-39aa883a0110
institution University of Oxford
last_indexed 2024-03-07T01:59:13Z
publishDate 2014
record_format dspace
spelling oxford-uuid:9cc39cdb-d7d1-473f-9ad4-39aa883a01102022-03-27T00:38:26ZEndonasal endoscopic transsphenoidal pituitary surgery: Early experience and outcome in paediatric Cushing's diseaseJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9cc39cdb-d7d1-473f-9ad4-39aa883a0110Symplectic Elements at Oxford2014Storr, HDrake, WMEvanson, JMatson, MBerney, DGrossman, AAkker, SAMonson, JAlusi, GSavage, MSavage, MSabin, IBackground Selective adenomectomy remains the first-line treatment for Cushing's disease (CD), until recently by microscopic transsphenoidal pituitary surgery. Endonasal transsphenoidal endoscopic surgery (ETES) is emerging as a novel, less invasive treatment for pituitary adenomas and has become the optimal surgical approach. Objective There are no published series for the treatment of paediatric CD by ETES, and we report our centre's preliminary results. Design Retrospective analysis. Patients Six paediatric patients (median age 15·8 years; range 11·7-17·0 years) fulfilled standard diagnostic criteria for CD. Preoperatively, no abnormality was identified on pituitary MR scanning in 3 (50%) patients, one had a macroadenoma. Bilateral petrosal sinus sampling demonstrated central ACTH secretion (IPS/P ACTH ratio ≥3·0, post-CRH) in 3/6 (50%) patients. The same neurosurgeon and endoscopic nasal surgeon undertook all the operations. Outcome measures Therapeutic outcome and rate of complications. Results Clinical recovery and biochemical 'cure' were achieved in 5 (83%) patients, and a corticotroph adenoma was confirmed histologically in all cured cases. One case developed post-operative CSF leak requiring lumbar drain insertion and patching. At a mean interval of 4·7 years (0·1-10·8 years) post-operatively, cured patients have shown no recurrence. One patient, with a large diffuse adenoma requiring more extensive surgery, has panhypopituitarism, and another patient has GH and gonadotrophin deficiencies. Conclusions Our experience shows that ETES for removing corticotroph adenomas in children, in most cases not visualized on MRI, is minimally invasive and gave excellent post-operative recovery/results. In skilled hands, this technique provides an alternative to conventional transsphenoidal microscopic surgery in managing paediatric CD. © 2013 John Wiley and Sons Ltd.
spellingShingle Storr, H
Drake, WM
Evanson, J
Matson, M
Berney, D
Grossman, A
Akker, SA
Monson, J
Alusi, G
Savage, M
Savage, M
Sabin, I
Endonasal endoscopic transsphenoidal pituitary surgery: Early experience and outcome in paediatric Cushing's disease
title Endonasal endoscopic transsphenoidal pituitary surgery: Early experience and outcome in paediatric Cushing's disease
title_full Endonasal endoscopic transsphenoidal pituitary surgery: Early experience and outcome in paediatric Cushing's disease
title_fullStr Endonasal endoscopic transsphenoidal pituitary surgery: Early experience and outcome in paediatric Cushing's disease
title_full_unstemmed Endonasal endoscopic transsphenoidal pituitary surgery: Early experience and outcome in paediatric Cushing's disease
title_short Endonasal endoscopic transsphenoidal pituitary surgery: Early experience and outcome in paediatric Cushing's disease
title_sort endonasal endoscopic transsphenoidal pituitary surgery early experience and outcome in paediatric cushing s disease
work_keys_str_mv AT storrh endonasalendoscopictranssphenoidalpituitarysurgeryearlyexperienceandoutcomeinpaediatriccushingsdisease
AT drakewm endonasalendoscopictranssphenoidalpituitarysurgeryearlyexperienceandoutcomeinpaediatriccushingsdisease
AT evansonj endonasalendoscopictranssphenoidalpituitarysurgeryearlyexperienceandoutcomeinpaediatriccushingsdisease
AT matsonm endonasalendoscopictranssphenoidalpituitarysurgeryearlyexperienceandoutcomeinpaediatriccushingsdisease
AT berneyd endonasalendoscopictranssphenoidalpituitarysurgeryearlyexperienceandoutcomeinpaediatriccushingsdisease
AT grossmana endonasalendoscopictranssphenoidalpituitarysurgeryearlyexperienceandoutcomeinpaediatriccushingsdisease
AT akkersa endonasalendoscopictranssphenoidalpituitarysurgeryearlyexperienceandoutcomeinpaediatriccushingsdisease
AT monsonj endonasalendoscopictranssphenoidalpituitarysurgeryearlyexperienceandoutcomeinpaediatriccushingsdisease
AT alusig endonasalendoscopictranssphenoidalpituitarysurgeryearlyexperienceandoutcomeinpaediatriccushingsdisease
AT savagem endonasalendoscopictranssphenoidalpituitarysurgeryearlyexperienceandoutcomeinpaediatriccushingsdisease
AT savagem endonasalendoscopictranssphenoidalpituitarysurgeryearlyexperienceandoutcomeinpaediatriccushingsdisease
AT sabini endonasalendoscopictranssphenoidalpituitarysurgeryearlyexperienceandoutcomeinpaediatriccushingsdisease